HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Descending thoracic aortic aneurysm repair with the aid of partial cardiopulmonary bypass: heparin-coated circuits versus nonheparin-coated circuits.

AbstractBACKGROUND:
We have performed descending thoracic aortic aneurysm repairs with partial cardiopulmonary bypass, including heparin-coated circuits. The aim of this study was to evaluate (i) the impact of partial cardiopulmonary bypass on distal organ function and surgical outcomes; and (ii) the effectiveness of using heparin-coated circuits for preventing bleeding complications.
METHODS:
From July 1980 to June 2004, 309 patients underwent descending thoracic aortic aneurysm repairs using partial cardiopulmonary bypass. Their mean age was 61 years (range 19-81 years). One hundred of the 309 patients underwent repair of descending thoracic aortic aneurysm with heparin-coated circuits. Blood data for renal and hepatic function were collected on the day before the operation and postoperative days.
RESULTS:
The in-hospital mortality was 15%. Distal organ dysfunction included spinal cord dysfunction in 2 patients (0.7%) and renal failure necessitating hemodialysis in 15 patients (5%, 15/297: excluded 12 dialysis patients). Multivariate analyses showed that preoperative hemodialysis and emergency operation were risk factors for operative mortality and that emergency operation was a risk factor for requiring hemodialysis. Renal and hepatic function normalized by 2 weeks after surgery. There were no significant differences between the heparin-coated group and nonheparin-coated group in amounts of packed red cells, fresh frozen plasma, and platelets transfused during the procedures.
CONCLUSIONS:
Our data showed that partial cardiopulmonary bypass is a safe and effective method for distal perfusion. Using this technique, descending thoracic aortic aneurysm repair can be performed with acceptable mortality and morbidity. However, the superiority of heparin-coated circuits over nonheparin-coated ones was not proved.
AuthorsKiyofumi Morishita, Nobuyoshi Kawaharada, Johji Fukada, Yoshikazu Hachiro, Yoshihiko Kurimoto, Yasuaki Fujisawa, Tatsuya Saito, Tomio Abe
JournalArtificial organs (Artif Organs) Vol. 29 Issue 4 Pg. 300-5 (Apr 2005) ISSN: 0160-564X [Print] United States
PMID15787624 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
  • Heparin
  • Creatinine
  • Alanine Transaminase
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Alanine Transaminase (blood)
  • Anticoagulants (administration & dosage)
  • Aortic Aneurysm, Thoracic (blood, surgery)
  • Cardiopulmonary Bypass (methods)
  • Creatinine (blood)
  • Female
  • Heparin (administration & dosage)
  • Humans
  • Kidney (physiopathology)
  • Liver (physiopathology)
  • Male
  • Middle Aged
  • Perfusion (instrumentation)
  • Postoperative Hemorrhage (prevention & control)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: